The Antibody Sequencing Services ecosystem comprises upstream, midstream, and downstream actors that generate, process, and apply antibody sequence data. Upstream, raw‑material suppliers provide nucleic‑acid reagents, enzymes, and flow cells. Midstream participants—technology providers and system integrators—offer next‑generation sequencing platforms, library‑prep automation, and bioinformatics pipelines. Downstream, service firms perform sequencing, data assembly, and annotation, while end‑users such as biopharma R&D labs, academic institutions, and diagnostic developers consume the curated sequences. Value is created by converting biological samples into actionable genetic information, captured through fee‑for‑service contracts, data licensing, and ancillary analytics.